References
- Hoffmann R, Mintz GS, Popma JJ, et al. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. J Am Coll Cardiol 1996;28:1134-1139. https://doi.org/10.1016/S0735-1097(96)00278-1
- Hoffmann R, Mintz GS, Dussaillant GR, et al. Patterns and mechanisms of in-stent restenosis. A serial intravascular ultrasound study. Circulation 1996;94:1247-1254. https://doi.org/10.1161/01.CIR.94.6.1247
- Mudra H, Regar E, Klauss V, et al. Serial follow-up after optimized ultrasound-guided deployment of Palmaz-Schatz stents. In-stent neointimal proliferation without significant reference segment response. Circulation 1997;95:363-370. https://doi.org/10.1161/01.CIR.95.2.363
- Weissman NJ, Wilensky RL, Tanguay JF, et al. Extent and distribution of in-stent intimal hyperplasia and edge effect in a non-radiation stent population. Am J Cardiol 2001;88:248-252. https://doi.org/10.1016/S0002-9149(01)01635-6
- Jimenez-Quevedo P, Sabaté M, Angiolillo DJ, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. J Am Coll Cardiol 2006;47:2172-2179. https://doi.org/10.1016/j.jacc.2006.01.063
- Serruys PW, Degertekin M, Tanabe K, et al. Vascular responses at proximal and distal edges of paclitaxel-eluting stents: serial intravascular ultrasound analysis from the TAXUS II trial. Circulation 2004;109:627-633. https://doi.org/10.1161/01.CIR.0000112566.87022.32
-
Honda Y, Grube E, de La Fuente LM, Yock PG, Stertzer SH, Fitzgerald PJ. Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the
$QP_2-eluting$ polymer stent system. Circulation 2001;104:380-383. https://doi.org/10.1161/hc2901.094149 - Cannon CP, Braunwald E, McCabe CH, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350:1495-1504. https://doi.org/10.1056/NEJMoa040583
- Hong YJ, Jeong MH, Lim JH, et al. The prognostic significance of statin therapy in acute myocardial infarction patients underwent percutaneous coronary intervention. Korean J Med 2003;65:426-435.
- Nissen SE, Tuzcu EM, Schoenhagen P, et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA 2004;291:1071-1080. https://doi.org/10.1001/jama.291.9.1071
- Libby P, Aikawa M. Mechanisms of plaque stabilization with statins. Am J Cardiol 2003;91(4A):4B-8B.
- Corsini A, Mazzotti M, Raiteri M, et al. Relationship between mevalonate pathway and arterial myocyte proliferation: in vitro studies with inhibitors of HMG-CoA reductase. Atherosclerosis 1993;101:117-125. https://doi.org/10.1016/0021-9150(93)90107-6
- Walter DH, Schachinger V, Elsner M, Dimmeler S, Zeiher AM. Platelet glycoprotein IIIa polymorphisms and risk of coronary stent thrombosis. Lancet 1997;350:1217-1219. https://doi.org/10.1016/S0140-6736(97)05399-3
- Suzuki M, Saito M, Nagai T, Saeki H, Kazatani Y. Prevention of positive coronary artery remodeling with statin therapy in patients with coronary artery diseases. Angiology 2006;57:259-265. https://doi.org/10.1177/000331970605700301
- Jensen LO, Thayssen P, Mintz GS, Carlier SG, Pedersen KE, Haghfelt T. Effect of simvastatin on coronary lesion site remodeling: a serial intravascular ultrasound study. Cardiology 2006;106:256-263. https://doi.org/10.1159/000093367
- Petronio AS, Amoroso G, Limbruno U, et al. Simvastatin does not inhibit intimal hyperplasia and restenosis but promotes plaque regression in normocholesterolemic patients undergoing coronary stenting: a randomized study with intravascular ultrasound. Am Heart J 2005;149:520-526. https://doi.org/10.1016/j.ahj.2004.10.032
Cited by
- Effect of Statin on the Reference Segments after Bare-Metal Stent Implantation vol.25, pp.4, 2010, https://doi.org/10.3904/kjim.2010.25.4.353